Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
UCLH is managing one of the three cancer hubs across London, so that during the COVID-19 coronavirus pandemic cancer surgery is available for patients with the most immediate needs.
-
One of our patients who is recovering from COVID-19 has been appearing across national media as she recounts her story and thanks the staff who saved her life.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
Information on how we ask for your consent to treatment, and Martha's Rule.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
File results
-
FOI/2022/0356 - Dog attacks and related injuries
-
FOI/2022/0358 - Infrastructure - data storage
-
FOI/2022/0360 - Staff contact details in charge of catering, vending and beverages
-
FOI/2022/0364 - Onsite incinerator
-
FOI/2022/0365 - Job roles at Trust with net zero in title
-
FOI/2022/0367 - Coagulation testing
-
FOI/2022/0368 - Recruitment data
-
FOI/2022/0369 - Inpatient mental health facilities
-
FOI/2022/0371 - Patients presented at A&E with dental health problems
-
FOI/2022/0372 - Number of offences relating to sexual misconduct